BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2965083)

  • 1. Neonatal myeloproliferative disorders in Down's syndrome and congenital leukemias.
    Paolucci G; Rosito P
    Haematologica; 1987; 72(6 Suppl):121-5. PubMed ID: 2965083
    [No Abstract]   [Full Text] [Related]  

  • 2. Congenital transient myeloproliferative disorder progressing to acute myeloid leukemia in Down's syndrome: a case report.
    Prabhu PD; V G; Niveditha SR; Gayathri BR; Keshavamurthy SR
    Indian J Pathol Microbiol; 2004 Jan; 47(1):48-50. PubMed ID: 15471129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital leukaemia and the neonatal myeloproliferative disorders associated with Down's syndrome.
    Weinstein HJ
    Clin Haematol; 1978 Feb; 7(1):147-54. PubMed ID: 148990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down's syndrome with transient myeloproliferative disorder.
    Dhaded SM; Das R; Kumar P; Narang A
    Indian Pediatr; 1996 Nov; 33(11):964-6. PubMed ID: 9141835
    [No Abstract]   [Full Text] [Related]  

  • 5. [GATA1 analysis in myeloproliferative disorders associated to trisomy 21].
    Fuster Soler JL; Norton A; Galera Miñarro A; Bermúdez Cortés M; Llinares Riestra ME; Ortuño Giner F
    An Pediatr (Barc); 2011 Jan; 74(1):31-7. PubMed ID: 20870473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro cell growth in neonates with Down's syndrome and transient myeloproliferative disorder.
    Denegri JF; Rogers PC; Chan KW; Sadoway J; Thomas JW
    Blood; 1981 Oct; 58(4):675-7. PubMed ID: 6456025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Test and teach. Number Seventy. Diagnosis: Transient myeloproliferative disorder in a child with Down's syndrome.
    Wright SJ; Kerwick AM; Rodwell RL; Taylor KM
    Pathology; 1993 Apr; 25(2):133, 207-8. PubMed ID: 8367191
    [No Abstract]   [Full Text] [Related]  

  • 8. Down syndrome and the myeloproliferative disorder.
    Amendola G; Amato L; Cirillo G; Dante G
    Clin Pediatr (Phila); 1990 Aug; 29(8):486. PubMed ID: 2145112
    [No Abstract]   [Full Text] [Related]  

  • 9. [Free plasma and cerebral amino acids in children with Down's syndrome].
    Abasheva GK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(7):1068-70. PubMed ID: 6457478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stainable blood platelet glycogen in various conditions.
    Hermanský F; Hrodek O; Matousová O; Cieslar P
    Acta Univ Carol Med Monogr; 1972; 53():165-71. PubMed ID: 4598518
    [No Abstract]   [Full Text] [Related]  

  • 11. Production of dysplastic platelets by peripheral blood megakaryoblasts in transient myeloproliferative disorder in Down syndrome.
    Chopra A; Kumar R; Kabra M; Anand M
    Platelets; 2008 Mar; 19(2):160-1. PubMed ID: 18297553
    [No Abstract]   [Full Text] [Related]  

  • 12. Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome.
    Zipursky A; Brown EJ; Christensen H; Doyle J
    Clin Lab Med; 1999 Mar; 19(1):157-67, vii. PubMed ID: 10403079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient myeloproliferative disorder in chromosomally normal newborn infant.
    Kalousek DK; Chan KW
    Med Pediatr Oncol; 1987; 15(1):38-41. PubMed ID: 2951583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic findings and clinical features in acute leukemia and transient myeloproliferative disorder in Down's syndrome.
    Hayashi Y; Eguchi M; Sugita K; Nakazawa S; Sato T; Kojima S; Bessho F; Konishi S; Inaba T; Hanada R
    Blood; 1988 Jul; 72(1):15-23. PubMed ID: 2968822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Myeloproliferative disorder associated with Down's syndrome].
    Zolezzi P; Calle H; Norambuena L; Mena MA
    Rev Chil Pediatr; 1980; 51(6):448-9. PubMed ID: 6452659
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hyperuricemia in Down's syndrome (etiology, significance, and possibilities of its modification)].
    Kucera J
    Cesk Pediatr; 1976 Jun; 31(6):316-9. PubMed ID: 134841
    [No Abstract]   [Full Text] [Related]  

  • 17. Cancers and immune related diseases associated with Down's syndrome: a record linkage study.
    Goldacre MJ; Wotton CJ; Seagroatt V; Yeates D
    Arch Dis Child; 2004 Nov; 89(11):1014-7. PubMed ID: 15499053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transient myeloproliferative syndrome or congenital leukemia in a newborn infant with Down syndrome?].
    Maszkiewicz W; Zarczynska B; Koralewska J
    Wiad Lek; 1989 May; 42(10):685-8. PubMed ID: 2534337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Congenital leukemia in a newborn infant with Down's syndrome].
    Ochocka M; Newecka T; Bogacka-Zatorska E
    Pediatr Pol; 1974 May; 49(5):607-10. PubMed ID: 4275390
    [No Abstract]   [Full Text] [Related]  

  • 20. Down syndrome and leukemia--an overview of cytogenetic and molecular events.
    Savaşan S; Taub JW; Ravindranath Y
    Turk J Pediatr; 1997; 39(4):519-31. PubMed ID: 9433155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.